Amylyx Pharmaceuticals, Inc.
USD18.70
+0.91 (+5.12%)
CEO
Joshua Cohen
IPO Date
2022-01-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.66
Prev. Close
$17.79
Day Low
$17.46
Day High
$18.75
52W Low
$5.97
52W High
$18.75
Market Cap
$1.55B
Volume
2.33M
| -0.9 |
| 31 Dec 2023 | FY | 93.3% | 12.9% | 11.4% | 9.5% | 0.01 | 5.66 | 20.1 |
| 31 Dec 2022 | FY | 86.5% | -892.4% | -58.2% | -50.7% | 0.02 | 8.20 | -12.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 58.2% | -83.3% | 0.00 | 6.03 | -11.9 |
| 31 Dec 2020 | FY | -3683.7% | -6504.6% | 63.4% | -299.8% | -0.02 | 1.86 | -24.1 |
| 31 Dec 2019 | FY | -734.4% | -1039.0% | 58.4% | -460.1% | -0.59 | 0.71 | -68.9 |
| -8.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -10.4% | -9.5% | 0.02 | 13.70 | -9.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -24.7% | -21.3% | 0.04 | 8.72 | -3.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -17.8% | -16.3% | 0.01 | 12.05 | -2.1 |
| 31 Dec 2024 | Q4 | 100.0% | 5646.0% | -22.8% | -19.4% | 0.01 | 6.67 | -1.7 |
| 30 Sept 2024 | Q3 | -94.5% | -17476.9% | -37.1% | -29.0% | 0.01 | 4.55 | -0.8 |
| 30 Jun 2024 | Q2 | 845.5% | 7106.5% | -27.8% | -21.9% | 0.01 | 4.66 | -0.4 |
| 31 Mar 2024 | Q1 | -31.3% | -134.0% | -36.6% | -28.5% | 0.01 | 4.48 | -0.4 |
| 31 Dec 2023 | Q4 | 91.4% | 4.4% | 1.1% | 0.9% | 0.01 | 5.66 | 52.4 |